View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Cisplatin 100 / Radiation, Head and Neck Tumors, adjuvant, cycle 3-5
Protocol-ID: 2971 V1.0 (Mini), PEMB200/CISP100/Radiation, Head and Neck Tumors, adj., C3-5Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
ST Radiotherapy: Simultaneous radiations |
| 2 Gy in 33 fractions, up to a total dose of 66 Gy |
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 18.07.2025